Dry Eye Drops vs. Prescription Eye Drops: Which Do You Actually Need?
OTC artificial tears and prescription dry eye drops treat different things. Here is how to tell which one is right for your situation — and when neither is enough.
Dry Eye Drops vs. Prescription Eye Drops: Which Do You Actually Need?
Walk into any pharmacy and you will find an entire aisle of eye drops claiming to treat dry eye. Then there are the prescription options — Restasis, Xiidra, Cequa — that your doctor may have mentioned. The differences between them are not obvious, and choosing the wrong product means spending money on something that will not help.
Here is a clear breakdown of what each type of drop does, who it helps, and when drops are not the right answer at all.
Over-the-Counter Artificial Tears
What They Do
Artificial tears supplement the aqueous (watery) component of the tear film. They temporarily increase tear volume and provide lubrication to the ocular surface. They do not treat the underlying cause of dry eye — they manage symptoms.
Types of OTC Drops
Preserved artificial tears: Contain preservatives (typically benzalkonium chloride or similar) that extend shelf life. Appropriate for occasional use (1–2 times per day). Preservatives can cause ocular surface toxicity with frequent use — if you need drops more than 4 times per day, switch to preservative-free.
Preservative-free artificial tears: Come in single-use vials. More expensive per dose but safe for frequent use. Recommended for moderate to severe dry eye, contact lens wearers, and patients with preservative sensitivity.
Gel drops: Thicker consistency that provides longer-lasting lubrication. Useful for nighttime use or for patients with severe symptoms. Can cause temporary blurring.
Ointments: The thickest formulation. Used primarily at night for severe dry eye. Not appropriate for daytime use due to significant blurring.
Key Ingredients to Look For
- Sodium hyaluronate (hyaluronic acid): Excellent water-retention properties; provides longer-lasting lubrication
- Carboxymethylcellulose (CMC): Common, effective viscosity agent
- Hydroxypropyl methylcellulose (HPMC): Similar to CMC
- Lipid-containing drops (e.g., Systane Complete, Refresh Optive Mega-3): Address the lipid layer deficiency of evaporative dry eye; more appropriate for MGD-related symptoms
Who Benefits from OTC Drops
- Mild, occasional dry eye symptoms
- Situational dryness (air travel, windy environments, screen use)
- As a supplement to in-office treatment
- Contact lens wearers with mild discomfort
Limitations
OTC drops treat symptoms, not causes. If you have meibomian gland dysfunction (MGD) — the most common cause of dry eye — artificial tears provide temporary relief but do not address the gland dysfunction driving your symptoms. Using drops multiple times per day indefinitely is not a treatment plan; it is symptom management.
Prescription Dry Eye Medications
Prescription dry eye medications work differently from artificial tears. They treat the underlying inflammation that drives chronic dry eye disease — particularly aqueous-deficient dry eye caused by lacrimal gland dysfunction.
Restasis (Cyclosporine 0.05%)
Restasis was the first FDA-approved prescription treatment for chronic dry eye disease. Cyclosporine is an immunomodulator that reduces the T-cell-mediated inflammation that damages the lacrimal glands and reduces tear production.
How it works: Reduces ocular surface inflammation, allowing the lacrimal glands to produce more tears over time.
Timeline: Restasis takes 3–6 months to show full benefit. Many patients experience stinging or burning initially, which typically diminishes over time.
Who it helps: Patients with aqueous-deficient dry eye caused by inflammatory lacrimal gland dysfunction. Less effective for evaporative dry eye (MGD).
Xiidra (Lifitegrast 5%)
Xiidra targets a different inflammatory pathway than Restasis. It blocks the LFA-1/ICAM-1 interaction that drives T-cell recruitment to the ocular surface.
How it works: Reduces ocular surface inflammation through a mechanism distinct from cyclosporine.
Timeline: Some patients notice improvement within 2 weeks; full benefit typically at 3 months.
Who it helps: Similar to Restasis — aqueous-deficient dry eye with an inflammatory component. Some patients who do not respond to Restasis respond to Xiidra, and vice versa.
Cequa (Cyclosporine 0.09%)
A higher-concentration cyclosporine formulation using a nanomicellar delivery system that improves corneal penetration. Approved in 2018.
How it works: Same mechanism as Restasis but with potentially improved delivery and efficacy.
Who it helps: Patients who have not responded adequately to Restasis.
Tyrvaya (Varenicline Nasal Spray)
A newer option — a nasal spray that stimulates the trigeminal parasympathetic pathway to increase natural tear production. Approved in 2021.
How it works: Stimulates the nasal mucosa to activate the lacrimal reflex arc, increasing tear production.
Who it helps: Patients with aqueous-deficient dry eye who prefer a non-eye-drop delivery method.
OTC vs. Prescription: Which Do You Need?
OTC drops treat the symptom. Prescription medications treat the inflammation causing the symptom. If you've been using drops daily for more than a few weeks without lasting relief, the underlying cause hasn't been addressed.
| Situation | Recommendation |
|---|---|
| Mild, occasional symptoms | Preservative-free OTC drops as needed |
| Moderate symptoms, frequent use | Preservative-free OTC drops + dry eye evaluation |
| Symptoms not controlled by OTC drops | Dry eye evaluation to determine cause |
| Aqueous-deficient dry eye (low tear production) | Prescription medication (Restasis, Xiidra, or Cequa) |
| Evaporative dry eye (MGD) | In-office treatment (IPL, RF, expression) + lipid-containing OTC drops |
| Mixed dry eye | Combination approach |
When Drops Are Not the Answer
If your dry eye is primarily caused by MGD — which accounts for approximately 86% of all dry eye cases — neither OTC drops nor prescription medications address the root cause. MGD is a gland dysfunction problem, not an inflammation problem (though inflammation is a secondary component).
The most effective treatments for MGD are in-office procedures: IPL therapy, OptiPlus RF, and meibomian gland expression. These address the gland obstruction and dysfunction that drives evaporative dry eye.
Frequently Asked Questions
Can I use OTC drops while taking prescription dry eye medication? Yes. Preservative-free artificial tears can be used alongside Restasis or Xiidra. Use the artificial tears at least 15 minutes before or after the prescription drop.
How do I know if I have aqueous-deficient or evaporative dry eye? A comprehensive dry eye evaluation — including Schirmer's test (tear production), tear breakup time, and meibography — will determine the type and cause of your dry eye. This is the essential first step before selecting treatment.
Are prescription dry eye drops covered by insurance? Restasis, Xiidra, and Cequa are covered under most prescription drug plans, though copays vary. Prior authorization may be required. Call your pharmacy benefits manager to verify coverage.
Schedule a Dry Eye Evaluation in Las Vegas
Trendsetter Eyewear is located at 1225 S Fort Apache Rd #145, Summerlin, Las Vegas. Contact us online or call (702) 479-5222 to schedule your dry eye evaluation.
Related reading:
- Dry eye treatment in Las Vegas — the full picture
- Meibomian gland dysfunction treatment — why drops often are not enough
- IPL treatment for dry eye — the most effective treatment for MGD
- Dry eye and screen time — a major contributing factor
Explore Topics
Written by
Dr. Cynthia Payne, OD
Content creator and writer sharing insights and stories.
